A Study of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML)

New York University Langone Health, New York

Mount Sinai Medical Center, New York

Roswell Park Comprehensive Cancer Center, Buffalo

Lineberger Comprehensive Cancer Center, Chapel Hill

Northside Hospital - The Blood and Marrow Transplant Group of Georgia, Atlanta

Sylvester Comprehensive Cancer Center, Miami

Vanderbilt - Ingram Cancer Center, Nashville

Ohio State University Comprehensive Cancer Center, Columbus

Franciscan Health Indianapolis (Blood and Marrow Transplantation), Indianapolis

Mayo Clinic, Rochester

The University of Chicago Medical Center, Chicago

The University of Kansas Clinical Research Center, Fairway

The University of Texas MD Anderson Cancer Center, Houston

University of California San Francisco, San Francisco

Smilow Cancer Hospital, New Haven